Juela, Rowena .

HRN: 26-38-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2024
CEFTRIAXONE 1G (VIAL)
12/17/2024
12/24/2024
IV
2 Grams
Q24H
CAP-MR, UTI
Waiting Final Action 
12/18/2024
CEFTRIAXONE 1G (VIAL)
12/18/2024
12/25/2024
IV
2g
OD
T/c Pneumonia
Waiting Final Action 
12/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/19/2024
12/25/2024
IV
4.5gm
Q8
Possible Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: